In Brief This Week: GE Healthcare, Karolinska Institutet; Illumina; Beckman Coulter, FDA; KeyGene, Donald Danforth Plant Science Center; More | GenomeWeb

NEW YORK (GenomeWeb News) – GE Healthcare said this week it won a tender offer to exclusively provide next-generation sequencing services to a Karolinksa Institutet research group. The first clinical study using the technology will be directed at identifying mutations and genetic variants associated with metastatic breast cancer. Karolinska will provide patient tissue samples for the study. SeqWright Genomics Services, a subsidiary of GE Healthcare, will provide the sequencing services for analysis of the tissue samples.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Biomedical research projects are generating a ton of data that still needs to be analyzed, NPR reports.

Theranos is retiring some of its board members, including Henry Kissinger and George Shultz, Business Insider reports.

The heads of 29 scientific societies and some 2,300 researchers call on President-elect Donald Trump to rely on and support science in two separate letters.

In Science this week: genetically modified flu virus could be key to new live vaccines, and more.